Company Monitoring Page for Novartis

latest headlines for company on cafepharma

GSK, Novartis, J&J and Pfizer lead pharma at making their meds accessible: report
Fierce Pharma
Tue, 01/26/21 - 11:30 pm
Tags:
GSK, Novartis, JNJ, Pfizer, accessibility
Novartis' Q4 earnings clouded by regulatory setbacks on inclisiran, Zolgensma
Endpoints
Tue, 01/26/21 - 11:30 am
Tags:
Novartis, earnings, inclisiran, Zolgensma
Novartis, GSK team up for $3.6m genetic diversity research in Africa
Pharmaceutical Business Review
Wed, 01/20/21 - 10:35 am
Tags:
Novartis, GSK, genetic diversity, Africa
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
Tags:
drug launches, Biogen, Eisai, aducanumab, efgartigimod, Argenx, Evrenzo, FibroGen, Astellas, AstraZeneca, Leqvio, Novartis, UCB Pharma, bimekizumab, Ascendis Pharma, Bluebird Bio, Bristol-Myers Squibb, ide-cel, liso-cel, AXS-05, Axsome Therapeutics, voclosporin, Aurinia
Novartis gets FDA breakthrough therapy status for ligelizumab to treat chronic spontaneous urticaria
Pharmaceutical Business Review
Fri, 01/15/21 - 09:49 am
Tags:
Novartis, breakthrough therapy, FDA, ligelizumab, chronic spontaneous urticaria
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how pharma works
Fierce Biotech
Tue, 01/12/21 - 11:04 am
Tags:
JPMHC 2021, pandemic, Novartis, COVID-19, R&D
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
Seeking Alpha
Mon, 01/11/21 - 06:56 pm
Tags:
Novartis, BeiGene, tiselizumab, cancer, drug development
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Tags:
Eli Lilly, Amgen, migraines, Allergan, Novartis, Biohaven, Teva Pharmaceutical
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
Motley Fool
Sat, 12/19/20 - 11:41 pm
Tags:
Novartis, FDA, cholesterol, inclisiran, complete response letter
Novartis acquires a small biotech and its trio of brain drugs
BioPharma Dive
Thu, 12/17/20 - 11:57 am
Tags:
Novartis, M&A, Cadent, Neuroscience
Amgen and Novartis tap TV host to jump-start migraine conversations—and fuel understanding
Fierce Pharma
Wed, 12/16/20 - 10:40 pm
Tags:
Aimovig, Amgen, Novartis, migraines, celebrity endorsements
Novartis' heart failure med Entresto wins FDA panel backing for bigger patient group—but just how much bigger?
Fierce Pharma
Wed, 12/16/20 - 11:35 am
Tags:
Novartis, Entresto, heart failure, heart failure with preserved ejection fraction
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Tue, 12/15/20 - 08:29 pm
Tags:
Roche, Novartis, Kesimpta, Ocrevus, MS, multiple sclerosis
Novartis raises the temp on Eylea rivalry with head-to-head trial win for Beovu in diabetic macular edema
Endpoints
Tue, 12/15/20 - 10:51 am
Tags:
Regeneron, Eylea, Novartis, Beovu, diabetic macular edema
Novartis/Incyte draw blank with Jakafi in COVID-19
Pharmaforum
Mon, 12/14/20 - 10:35 am
Tags:
Novartis, Incyte, Jakafi, COVID-19, clinical trials
Novartis’ $9.7B PCSK9 drug nabs first OK — now comes the challenge of finding a market
Endpoints
Fri, 12/11/20 - 11:06 am
Tags:
Europe, Novartis, PCSK9, inclisiran
SABCS: Novartis touts Kisqali's 5-year breast cancer survival, advantage over Pfizer's Ibrance
Fierce Pharma
Wed, 12/9/20 - 10:51 am
Tags:
Novartis, Kisqali, breast cancer, SABCS
ASH20: Out to shake up CML once again, Novartis lays out head-to-head between third-gen Gleevec scion and Pfizer rival
Endpoints
Tue, 12/8/20 - 11:08 pm
Tags:
ASH2020, Novartis, CML, asciminib, Pfizer
Novartis signs ophthalmology AI deal with RetinAI
Pharmaforum
Tue, 12/8/20 - 10:35 am
Tags:
Novartis, RetinAI, opthalmology
ASH: Novartis makes its Kymriah case in follicular lymphoma, but another Gilead showdown awaits
Fierce Pharma
Sat, 12/5/20 - 11:38 pm
Tags:
ASH2020, Novartis, Kymriah, follicular lymphoma, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.